DREPAMASSE Study – Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry
Condition(s):Sickle Cell Disease; Infant, Newborn, Disease; DrepanocytosisLast Updated:May 16, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Sickle Cell Disease; Infant, Newborn, Disease; DrepanocytosisLast Updated:May 16, 2023Completed
Condition(s):Expanded Newborn Screening; Parental AcceptabilityLast Updated:November 1, 2023Completed
Condition(s):Neonatal ScreeningLast Updated:February 8, 2016Completed
Condition(s):Angelman Syndrome; Prader-Willi SyndromeLast Updated:September 6, 2023Completed
Condition(s):Spinal Muscular AtrophyLast Updated:November 2, 2016Completed
Condition(s):Pompe DiseaseLast Updated:January 1, 2013Completed
Condition(s):Genetic DiseaseLast Updated:March 12, 2024Recruiting
Condition(s):Spinal Muscular AtrophyLast Updated:March 10, 2021Completed
Condition(s):Spinal Muscular AtrophyLast Updated:February 14, 2022Completed
Condition(s):AdrenoleukodystrophyLast Updated:July 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.